ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 75 filers reported holding ADMA BIOLOGICS INC in Q4 2019. The put-call ratio across all filers is 2.88 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,501,238 | +1.0% | 419,340 | +4.1% | 0.00% | – |
| Q2 2023 | $1,485,985 | +21.4% | 402,706 | +8.9% | 0.00% | – |
| Q1 2023 | $1,224,243 | -14.7% | 369,862 | -0.1% | 0.00% | – |
| Q4 2022 | $1,436,000 | +57.8% | 370,232 | -1.0% | 0.00% | – |
| Q3 2022 | $910,000 | +19.1% | 374,156 | -3.0% | 0.00% | – |
| Q2 2022 | $764,000 | +1636.4% | 385,573 | +1701.7% | 0.00% | – |
| Q4 2020 | $44,000 | -62.1% | 21,400 | -56.0% | 0.00% | – |
| Q3 2020 | $116,000 | -14.7% | 48,680 | +4.9% | 0.00% | – |
| Q2 2020 | $136,000 | +46.2% | 46,410 | +43.7% | 0.00% | – |
| Q1 2020 | $93,000 | -1.1% | 32,300 | +36.9% | 0.00% | – |
| Q4 2019 | $94,000 | -54.1% | 23,600 | -48.7% | 0.00% | – |
| Q3 2019 | $205,000 | +7.3% | 46,005 | -6.9% | 0.00% | – |
| Q2 2019 | $191,000 | – | 49,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Velan Capital Investment Management LP | 4,000,000 | $15,520,000 | 13.71% |
| Stonepine Capital Management, LLC | 6,940,000 | $26,927,200 | 11.33% |
| Caligan Partners LP | 2,676,093 | $10,383,241 | 8.64% |
| Altium Capital Management LP | 2,870,000 | $11,135,600 | 5.66% |
| AWM Investment Company, Inc. | 6,015,000 | $23,338,200 | 3.36% |
| EAM Investors, LLC | 1,749,598 | $6,788,440 | 1.40% |
| Perceptive Advisors | 11,900,255 | $46,172,989 | 1.30% |
| EAM Global Investors LLC | 836,323 | $3,244,933 | 0.84% |
| Potomac Capital Management, Inc. | 120,000 | $466 | 0.54% |
| OBERWEIS ASSET MANAGEMENT INC/ | 536,900 | $2,083,172 | 0.44% |